Cullinan Therapeutics Cash, Cash Equivalents, Investments, And Interest Receivable Were $664.9M As Of June 30, 2024. Cullinan Continues To Expect Its Cash Resources To Provide Runway Into 2028 Based On Its Current Operating Plan
Cullinan Therapeutics Cash, Cash Equivalents, Investments, And Interest Receivable Were $664.9M As Of June 30, 2024. Cullinan Continues To Expect Its Cash Resources To Provide Runway Into 2028 Based On Its Current Operating Plan
截至2024年6月30日，Cullinan Therapeutics的現金、現金等價物、投資和應收利息總額爲6,649萬美元。根據其當前的運營計劃，Cullinan仍然預計其現金資源可提供資金到2028年。
Cullinan Therapeutics Cash, Cash Equivalents, Investments, And Interest Receivable Were $664.9M As Of June 30, 2024. Cullinan Continues To Expect Its Cash Resources To Provide Runway Into 2028 Based On Its Current Operating Plan
截至2024年6月30日，Cullinan Therapeutics的現金、現金等價物、投資和應收利息總額爲6,649萬美元。根據其當前的運營計劃，Cullinan仍然預計其現金資源可提供資金到2028年。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間